Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Strategic Education
STRA
$1.85B
| $1.07M | ﹤0.01% |
10,286
| – | – |
|
1602
Goosehead Insurance
GSHD
$2.2B
| $1.06M | ﹤0.01% |
15,972
+5,705
| +56% | +$436K |
|
1603
Kinetik
KNTK
$3.72B
| $1.06M | ﹤0.01% |
26,642
+19,181
| +257% | +$658K |
|
1604
Outfront Media
OUT
$5.61B
| $1.06M | ﹤0.01% |
64,106
-42
| -0.1% | -$592 |
|
1605
Hillman Solutions
HLMN
$1.54B
| $1.06M | ﹤0.01% |
99,498
+5
| +0% | +$47 |
|
1606
Assurant
AIZ
$13.8B
| $1.06M | ﹤0.01% |
5,607
-299
| -5% | -$52.1K |
|
|
RCM
1607
DELISTED
R1 RCM Inc. Common Stock
RCM
| $1.05M | ﹤0.01% |
81,987
+221
| +0.3% | +$2.57K |
|
1608
MasterBrand
MBC
$1.06B
| $1.05M | ﹤0.01% |
56,171
-1
| -0% | -$16 |
|
1609
United Airlines
UAL
$39.4B
| $1.05M | ﹤0.01% |
21,965
+4
| +0% | +$171 |
|
1610
Transmedics
TMDX
$2.64B
| $1.05M | ﹤0.01% |
14,198
+1
| +0% | +$82 |
|
1611
Delek US
DK
$4.16B
| $1.05M | ﹤0.01% |
34,172
-14
| -0% | -$379 |
|
1612
Sunstone Hotel Investors
SHO
$2.19B
| $1.05M | ﹤0.01% |
94,241
+4
| +0% | +$44 |
|
1613
Clearfield
CLFD
$411M
| $1.05M | ﹤0.01% |
33,941
+777
| +2% | +$22.3K |
|
1614
Werner Enterprises
WERN
$2.24B
| $1.05M | ﹤0.01% |
26,777
+1
| +0% | +$40 |
|
1615
Standex International
SXI
$3.59B
| $1.04M | ﹤0.01% |
5,730
| – | – |
|
1616
Bloomin' Brands
BLMN
$741M
| $1.04M | ﹤0.01% |
36,352
+2
| +0% | +$54 |
|
1617
CareTrust REIT
CTRE
$9.91B
| $1.04M | ﹤0.01% |
42,748
+3
| +0% | +$68 |
|
1618
Intellia Therapeutics
NTLA
$1.49B
| $1.04M | ﹤0.01% |
37,841
+6
| +0% | +$167 |
|
1619
Celestica
CLS
$38.1B
| $1.04M | ﹤0.01% |
+23,108
| New | +$877K |
|
1620
Progress Software
PRGS
$1.66B
| $1.04M | ﹤0.01% |
19,480
+1
| +0% | +$55 |
|
|
SQSP
1621
DELISTED
Squarespace, Inc.
SQSP
| $1.03M | ﹤0.01% |
28,376
+30
| +0.1% | +$975 |
|
1622
Twist Bioscience
TWST
$5.7B
| $1.03M | ﹤0.01% |
30,168
+3
| +0% | +$108 |
|
1623
Trinity Industries
TRN
$2.48B
| $1.03M | ﹤0.01% |
37,034
+2
| +0% | +$52 |
|
1624
Skyward Specialty Insurance
SKWD
$2.43B
| $1.03M | ﹤0.01% |
27,530
+20,835
| +311% | +$705K |
|
|
VRNT
1625
DELISTED
Verint Systems
VRNT
| $1.03M | ﹤0.01% |
31,040
-5
| -0% | -$150 |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.